What is the market for Medical cannabis?
Medical
Cannabis Market
Highlights
Medical
cannabis, also known as medical marijuana, is an herbal drug derived from
plants of the genus Cannabis used to treat a specific symptom or disease.
Although the word cannabis refers specifically to the plant genus, it is also
used interchangeably with marijuana, which describes the crude drug isolated
from the plants’ leaves and flowers.
The
global Medical Cannabis Market Size is expected to cross USD 33,210.21 million
by 2027 at a CAGR of 18.14% during the forecast period 2020-2027.
The key
factors that drive the global medical cannabis market trends
are the rising research & development activities and financial support by
various government and private organizations for cannabinoid research. However,
stringent government policies and increasing illegal use of marijuana sizes are
anticipated to hamper the market growth.
Segment
Analysis
The
global medical cannabis market insights has been segmented based on product type,
derivative, route of administration, application, and distribution channel.
The
market, based on product type, has been segregated into solid,
dissolvable/powders, oil, and ointment & creams. Based on derivative, the
market is bifurcated into cannabidiol and tetrahydrocannabinol. Based on route
of administration, the global medical cannabis market has been segmented into
inhalation, oral, and topical.
Based
on application it is divided into pain management, neurological health
management, and mental health management. The inhalation segment dominated the
market segment is expected to register the fastest growth in the application
segment of the global medical cannabis market during the forecast
period. The medical cannabis market, by distribution channel, is segmented
into hospital pharmacy, retail pharmacy, and online pharmacy.
Regional
Analysis
The
Americas dominated the global medical cannabis market by accounting for the
largest share in 2020. This large market share is due to medical cannabis
legalization in 37 US states and the increasing adoption of products. The
presence of major manufacturers, the rising adoption of medical cannabis
products, and an increasing number of companies involved in R&D activities
are driving the growth of the market in this region. Europe holds a strong share
in the global medical cannabis market. It is the second-largest market due to
an increasing number of European countries legalizing cannabis for medical
purposes.
Additionally,
prominent research and manufacturing activities in the region are anticipated
to increase the market size in this region. The increasing prevalence of
diseases such as multiple sclerosis, epilepsy, Alzheimer’s disease, Parkinson’s
disease, post-traumatic stress disorder, depression, and anxiety are fuelling
the market growth in Europe. Asia-Pacific is expected to have a favourable
growth rate during the forecast period, owing to the huge patient pool of
cancer and government initiatives of healthcare reforms. It holds the
third-largest position in the global medical cannabis market. The Middle East
would depict the least growth due to major factors, such as underdeveloped
regulations and lower adoption rates. The region is expected to witness a
restricted growth due to stringent government policies.
Medical Cannabis Market Players
The global medical cannabis market players - Canopy
Growth Corporation (Canada), Cannabis Sativa, Inc. (US), GW Pharmaceuticals
plc. (UK), Emerald Health Therapeutics (Canada), Tilray, Inc. (Canada), Aurora
Cannabis Inc. (Canada), Cara Therapeutics (US), Medical Marijuana, Inc. (US),
GB Sciences, Inc. (US), and Canndoc (Israel).
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment